Hydroxylamine → HCID 11230046、化合物
反応式
[O:1]=[C:2]1[NH:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[CH2:5][CH2:4][CH:3]1[CH2:13][C:14]([OH:16])=O.C(C(Cl)=O)C.[NH2:22][OH:23]>>[OH:23][NH:22][C:14](=[O:16])[CH2:13][CH:3]1[C:2](=[O:1])[NH:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[CH2:5][CH2:4]1参加物
4
実験手順
The (2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)-acetic acid is treated with EtCOCl and freshly prepared NH2OH by following a similar procedure described in example 1 to provide the title compound N-hydroxy-2-(2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)-acetamide which is purified by preparative LC/MS. 1H NMR (400 MHz, MeOD) δ 7.28 (m, 2H), 7.17(dt, 1H, J=1.2 Hz, J=8.0 Hz), 7.04 (dd, 1H, J=1.2 Hz, J 8.0 Hz), 2.90 (m, 2H), 2.72 (m, 1H), 2.55 (m, 1H), 2.28 (m, 1H), 2.15 (m, 1H), 1.97 (m, 1H). MS: (ES+): 235.3 [M+1].
出典と根拠
- ORDレコード
- ord-ce66c17465294af1862992d9960b72b3
- 出典データセット
- uspto-grants-2007_08
- 特許番号
- US07253164B2
反応ノート
読み込み中…